PRE PRENETICS GLOBAL LIMITED

Prenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market

Prenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market

Adds Renowned Clinical Experts Dr. Jeremy London and Dr. Amy Shah to Existing Team from Mayo Clinic, Cedars-Sinai, NASA and Yale University

CHARLOTTE, N.C., March 18, 2025 (GLOBE NEWSWIRE) --  , the premium supplements brand co-founded by David Beckham, today announced the addition of two distinguished new members, Dr. Jeremy London and Dr. Amy Shah, to its world-class (SAB). These additions underscore IM8’s unwavering commitment to leading innovation in science, longevity and human performance.

Newly joining IM8’s SAB are:

Dr. Amy Shah – An acclaimed integrative medicine physician and double board-certified expert in Internal Medicine, Dr. Shah focuses on gut health, hormonal balance and nutrition. Her practical, evidence-based approach and extensive experience in integrative wellness will guide IM8’s continued development of comprehensive wellness solutions.

Dr. Jeremy London – With over 25 years of experience, Dr. London is a board-certified and renowned cardiothoracic surgeon specializing in preventive cardiovascular health. He is recognized as a leader in minimally invasive heart valve treatments and thoracic aortic aneurysm repair. Dr. London’s deep commitment to preventive care and patient education will further enhance IM8’s cardiovascular health product initiatives.

“Our Scientific Advisory Board has been instrumental since day one in helping us set industry-leading standards," said Danny Yeung, co-founding partner and CEO of IM8. “We’re eager to welcome Dr. Jeremy London and Dr. Amy Shah, whose exceptional expertise will elevate our innovative research and product development even further, reinforcing IM8’s position as a trusted leader in health and wellness.”

Since its inception, IM8’s SAB has featured top experts whose contributions have been crucial to the company’s product development. Among those experts include:

Dr. Dawn Mussallem – Integrative Oncologist at Mayo Clinic

Dr. Mussallem is a distinguished consultant in the Division of Hematology Oncology at Mayo Clinic, where she has served as a clinician for over 20 years, and an Assistant Professor of Medicine. She is a double board-certified lifestyle medicine breast specialist at The Robert and Monica Jacoby Center for Breast Health and founded the Integrative Medicine and Breast Health Program at Mayo Clinic Florida.

Dr. Jim Green – Former Chief Scientist of NASA

Dr. Green has led numerous groundbreaking NASA missions, including Mars Rover landings and the New Horizons mission to Pluto. His expertise in space science and biomedical innovations uniquely benefits IM8’s approach to health and longevity.

Dr. James DiNicolantonio – Cardiovascular Research Scientist and Author

Dr. DiNicolantonio is widely recognized for his research on nutrition, metabolism and human health. He is known for translating complex nutritional science into actionable health advice, strengthening IM8’s nutritional offerings. He is the author/co-author of over 250 academic publications in the medical literature spanning nutrition, nutraceuticals, cardiovascular health, longevity and overall health.

Dr. Suzanne Devkota – Director of Microbiome Research Lab at Cedars-Sinai Medical Center

Dr. Devkota’s pioneering research in microbiome science and its role in chronic diseases aligns closely with IM8’s commitment to developing innovative gut-health solutions. With over 15 years of experience in the field, Dr. Devkota’s research emphasizes the critical connection between the microbiome and overall health, highlighting the potential for microbiome-based therapies.

Dr. David Katz – Founding Director of Yale-Griffin Prevention Research Center

Dr. Katz is an internationally recognized expert in preventive medicine, nutrition and public health. His contributions have significantly influenced IM8’s scientifically-validated nutrition and preventive healthcare solutions. He has roughly 250 peer-reviewed publications and has authored/co-authored 19 books to date including multiple editions of leading textbooks in nutrition, preventive medicine, and epidemiology.

Dr. Stephen Anton – Professor in the Department of Physiology and Aging at University of Florida

Prof. Stephen Anton is a renowned expert in aging and metabolic health, with over 20 years of experience in the field. He is a Distinguished Professor at the University of Florida with a primary appointment in the Department of Physiology and Aging. Prof. Anton’s research focuses on the interplay between lifestyle factors, metabolic health, and aging, with a particular emphasis on the benefits of caloric restriction, intermittent fasting, and physical activity.

IM8’s flagship product, , exemplifies the SAB’s foundational role. This clinically-validated all-in-one daily powder supplement is designed to replace up to 16 supplements, enhancing energy, immunity, digestion and longevity. Supported by rigorous clinical trials and third-party NSF certification for Sport, it demonstrates IM8’s dedication to quality, transparency and efficacy.

The global supplements market is valued at by 2028, driven by growing consumer demand for credible, scientifically-backed products.

About IM8

IM8 is the pinnacle of premium core nutrition, born from a collaboration between David Beckham as a co-founding partner, and an elite team of scientists spanning medical professionals, academia and space science. Combining cutting-edge science with nature’s most potent ingredients, IM8 delivers a holistic, science-backed approach to health, empowering you to live your most vibrant life. IM8’s flagship product, Daily Ultimate Essentials is an all-in-one powder supplement engineered to replace 16 different supplements in a delicious drink and is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors or sweeteners. IM8 is a subsidiary of Prenetics, a leading global health sciences company dedicated to advancing consumer health.

Media Contact

Camille Livesay

Jack Taylor Public Relations



EN
18/03/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PRENETICS GLOBAL LIMITED

 PRESS RELEASE

Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering B...

Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity Final Milestone in Strategic Transformation Positions Company to Accelerate IM8 Global Expansion with Zero Debt Q4 and Full-Year 2025 Financial Results to be Announced on February 18, 2026 NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced the completion of the sale of its 35% equit...

 PRESS RELEASE

Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M AR...

Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY Total Revenue Increased 480% to $92.4 million for Full Year 2025, Q4 Revenue reached $36.6 millionIM8 Reaches $10 Million in Monthly Revenue in December 2025, Achieving $120M ARR MilestoneStrategic Transformation Completed with Divestitures and Focus on IM8 Total Adjusted Liquidity2 of Approximately $171 Million Following Sale of Insighta Stake to Tencent, with Zero DebtCompany to Host Earnings Call on February 18, 2026, at 10:00 a.m. ET and latest investor deck can be found at N...

 PRESS RELEASE

Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. ...

Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors Appointment Strengthens Board with Deep Clinical and Commercial Expertise in Healthspan Optimization, Aligning with IM8 Growth Strategy NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced the appointment of Dr. Darshan Shah as an independent director to its Board of Directors (the “Board”), effective Februa...

 PRESS RELEASE

Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering B...

Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity Final Milestone in Strategic Transformation Positions Company to Accelerate IM8 Global Expansion with Zero Debt Q4 and Full-Year 2025 Financial Results to be Announced Pre-Market on February 18, 2026 NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced the completion of the sale of it...

 PRESS RELEASE

Formula 1 Phenom Ollie Bearman Joins Prenetics’ IM8 Health as Global A...

Formula 1 Phenom Ollie Bearman Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder Ollie Bearman becomes the latest elite athlete to invest in NASDAQ:PRE, underscoring a deep belief in the brand’s mission and products.IM8, co-founded by David Beckham, continues to attract top-tier athletes who prioritize scientifically validated and trusted nutritional support.IM8 has become one of the fastest-growing supplement brands globally, achieving an extraordinary US$100 million in Annual Recurring Revenue in just 11 months from launch.Bearman’s rapid rise – including a historic points-...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch